Kenneth Marek Selected Research

Kenneth Marek Research Topics

Disease

55	Parkinson Disease (Parkinson's Disease) 04/2024 - 01/2003
12	Disease Progression 04/2024 - 12/2008
7	Parkinsonian Disorders (Parkinsonism) 01/2017 - 12/2004
6	Movement Disorders (Movement Disorder) 12/2023 - 08/2014
6	Anosmia 12/2023 - 03/2012
5	Tremor (Tremors) 04/2024 - 10/2015
5	Dementia (Dementias) 02/2024 - 08/2014
5	Cognitive Dysfunction 02/2024 - 11/2017
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2014
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
3	Nausea 01/2023 - 12/2004
3	Dyskinesias (Dyskinesia) 11/2012 - 07/2004
2	REM Sleep Behavior Disorder 04/2024 - 01/2021
2	Hypokinesia (Bradykinesia) 01/2021 - 12/2018
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 10/2015
2	Inflammation (Inflammations) 08/2017 - 02/2009
2	Hallucinations (Hallucination) 01/2016 - 08/2013
1	Constipation 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Panic Disorder (Panic Attack) 01/2022
1	Confusion (Bewilderment) 01/2022
1	Kidney Calculi (Kidney Stone) 01/2021
1	Synucleinopathies 01/2021
1	Prodromal Symptoms 01/2020
1	Amyloid Plaque 09/2019
1	Olfaction Disorders (Cacosmia) 11/2017
1	Fatigue 10/2015
1	Orthostatic Hypotension (Postural Hypotension) 08/2013
1	Headache (Headaches) 12/2004
1	Infections 12/2004
1	Edema (Dropsy) 07/2004
1	Sleepiness 07/2004

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2008
20	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2023 - 01/2003
10	SynucleinsIBA 04/2024 - 10/2013
6	Dopamine (Intropin)FDA LinkGeneric 06/2023 - 07/2007
4	Uric Acid (Urate)IBA 01/2021 - 06/2008
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2017
4	Leucine (L-Leucine)FDA Link 01/2021 - 01/2017
3	Monoamine Oxidase (MAO)IBA 04/2024 - 09/2019
3	Amyloid (Amyloid Fibrils)IBA 02/2024 - 10/2013
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
3	alpha-SynucleinIBA 01/2021 - 02/2009
3	Levodopa (L Dopa)FDA LinkGeneric 01/2014 - 07/2004
3	Pramipexole (Mirapex)FDA LinkGeneric 08/2013 - 07/2004
2	Monoclonal AntibodiesIBA 04/2024 - 01/2022
2	venglustatIBA 01/2023 - 01/2022
2	tau Proteins (tau Protein)IBA 09/2019 - 10/2013
2	3,9-bis((ethylthio)methyl)-K-252aIBA 01/2018 - 08/2011
2	ioflupaneIBA 01/2017 - 08/2014
2	AntioxidantsIBA 08/2011 - 06/2008
1	Prednisolone (Predate)FDA LinkGeneric 12/2023
1	AcidsIBA 01/2023
1	ceramide glucosyltransferaseIBA 01/2023
1	GlycosphingolipidsIBA 01/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Inosine FDA Link 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	serum P-component (CIt)IBA 01/2020
1	(18F)GTP1IBA 09/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2019
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 11/2018
1	solanezumabIBA 10/2017
1	florbetapirIBA 10/2017
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2015
1	Testosterone (Sustanon)FDA Link 01/2014
1	Dihydroxyphenylalanine (Dopa)IBA 11/2012
1	purineIBA 06/2008
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 12/2004
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2003

Therapy/Procedure

8	Therapeutics 04/2024 - 07/2004
3	Activities of Daily Living (ADL) 01/2017 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 11/2012
1	Endurance Training 10/2022